Molecular geneticist Elli Papaemmanouil, whose lab brings together clinical, computational, molecular, and mathematic research investigators interested in the role of acquired mutations in cancer development and how these determine clinical phenotype and response to therapy.
Next-generation sequencing has enabled scientists to collect an astonishing amount of data about the genomes of both normal and cancerous cells. Through computational oncology, our investigators are creating tools that enable them to navigate and analyze this vast quantity of information and translate molecular insights into treatments that can benefit patients.
Memorial Sloan Kettering is offering an unprecedented academic opportunity for new research faculty to join our recently expanded computational oncology initiative, under the leadership of Sohrab Shah, PhD.
